OncologyEducation presents MedOncNow

Check or Checkmate Ipi/Nivo in HCC with Dr. Hatim Karachiwala


Listen Later

In this episode of MedOncNow, Dr. Hatim Karachiwala discusses where IPI/NIVO is positioned in the first-line treatment options of advanced HCC. We discuss the regimen's efficacy with a focus on toxicity management.

This is particularly timely as BMS has a compassionate access program for Ipilimumab and Nivolumab for advanced HCC.

...more
View all episodesView all episodes
Download on the App Store

OncologyEducation presents MedOncNowBy OncologyEducation